American Oncology Network, Inc. (NASDAQ: AONC), headquartered in Irving, Texas, is a leading provider of administrative and clinical support services to community-based oncology and hematology practices. The company partners with independent cancer care physicians, delivering centralized infrastructure and resources that allow clinicians to concentrate on patient treatment and outcomes rather than back-office operations.
The company’s suite of services encompasses practice management, revenue cycle management, procurement, information technology, compliance and regulatory support, along with clinical research coordination. By offering a comprehensive platform that integrates billing and coding, supply chain optimization, and access to both industry-sponsored and investigator-initiated clinical trials, American Oncology Network enables affiliated practices to improve operational efficiency, reduce overhead, and enhance patient access to cutting-edge therapies.
American Oncology Network works with a broad network of community oncology practices across multiple U.S. regions, including key markets in the Southeast, Midwest and Southwest. Through its affiliation model, the company supports physician-owned practices in delivering personalized care in outpatient settings, combining the benefits of local clinical relationships with the scale and expertise of a national support organization.
Founded to foster collaboration among community oncology providers, American Oncology Network is led by a senior management team with extensive experience in oncology practice administration, healthcare finance and clinical operations. The company’s leadership focuses on advancing value-based cancer care by leveraging data analytics, quality-management initiatives and strategic partnerships with pharmaceutical and biotechnology firms.
AI Generated. May Contain Errors.
Free AONC Stock Alerts